Sign inJoin waitlistJoin the waitlist

AK

Andrew Krivoshik

Clinical Pharmacology

Credentials: · · · · · · ·

History

Pediatric Hematology Oncology
Duke University Hospital
2002–2004
University of Illinois at Urbana-ChampaignPhD
1990–2001
Pediatrics
Mayo Clinic College of Medicine and Science
1999–2000
University of Illinois College of Medicine
1995–1999

Research

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
New England Journal of Medicine · 2018 · 798 citations
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour…
The Lancet Oncology · 2010 · 731 citations
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
Journal of Clinical Oncology · 2012 · 692 citations

Andrew Armstrong
7 papers
CH
Celestia Higano
6 papers
Cora Sternberg
6 papers
TB
Tomasz Beer
5 papers
Frank Balis
4 papers
John Maris
4 papers
Susan Cohn
4 papers
Brigitte Widemann
3 papers
Charles Rudin
3 papers
Geoffrey Shapiro
3 papers
Peter Adamson
3 papers
TP
Teresa Parli
3 papers